BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7006795)

  • 21. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival.
    Ffrench M; Magaud JP; Ffrench P; Berger F; Devaux Y; Duhaut P; Shen N; Coiffier B; Bryon PA
    Am J Clin Pathol; 1994 Apr; 101(4):413-20. PubMed ID: 8160629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface markers of lymphocytes in the snake, Spalerosophis diadema. I. Investigation of lymphocyte surface markers.
    Mansour MH; El Ridi R; Badir N
    Immunology; 1980 Aug; 40(4):605-11. PubMed ID: 7000688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lymphocyte surface markers during treatment of non-Hodgkin's lymphomas].
    Trepińska E; Burchardt K
    Z Gesamte Inn Med; 1981 Sep; 36(18):681-2. PubMed ID: 6976047
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ; Frizzera G; Kersey JH; Goldman AI
    N Engl J Med; 1979 Sep; 301(10):512-8. PubMed ID: 313510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive ability of Lukes-Collins classification for immunologic phenotypes of childhood non-Hodgkin lymphoma: an institutional series and literature review.
    Crist WM; Kelly DR; Ragab AH; Roper M; Dearth JC; Castleberry RP; Flint A
    Cancer; 1981 Nov; 48(9):2070-5. PubMed ID: 6975158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunologic diagnosis of variants of chronic lymphoid leukemia and lymphosarcomas].
    Samoĭlova RS; Ol'shevskaia EV; Polianskaia AM
    Ter Arkh; 1981; 53(11):73-8. PubMed ID: 7041315
    [No Abstract]   [Full Text] [Related]  

  • 29. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
    Aisenberg AC
    N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphomas. Correlation with clinical features.
    Cossman J; Jaffe ES; Fisher RI
    Cancer; 1984 Oct; 54(7):1310-7. PubMed ID: 6380700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificities and some properties of human T and B lymphocyte antisera.
    Morita T; Morita R; Takagi S; Shimoyama N; Nagai K
    Tohoku J Exp Med; 1981 Mar; 133(3):275-84. PubMed ID: 6171909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.
    Chen WL; Tsai WC; Chao TY; Sheu LF; Chou JM; Kao WY; Chen YC; Ho CL
    Ann Hematol; 2010 Jun; 89(6):553-62. PubMed ID: 20012434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic basis for the redefinition of malignant lymphomas.
    Parker JW
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):670-86. PubMed ID: 386778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
    Schwarze EW
    Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
    Mitarnun W; Suwiwat S; Pradutkanchana J
    Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface markers in non-Hodgkin's lymphomas.
    Rudders RA
    Hosp Pract (Off Ed); 1983 Jan; 18(1):161-4, 169-70, 172 passim. PubMed ID: 6401266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte surface markers.
    Thomson AW
    Scott Med J; 1979 Apr; 24(2):118-20. PubMed ID: 315100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.